Steering Committees

The consortium’s cancer, inflammation & immunity, metabolic disorders, and neuroscience steering committees are responsible for identifying and moving forward promising pre-competitive biomarkers projects for implementation by the Consortium, as well as overseeing each individual project under its purview.

The members of each Steering Committee represent a variety of sectors, including academia, government, industry, and non-profit/advocacy organizations, and are led by two co-chairs representing two of the following three sectors: academia, government or industry.

See below for the membership of each consortium steering committee.